Assessment of the Impact of Body Position on Diaphragmatic Excursion in Obese Patients to Improve Proactice in Respiratory Kinesitherapy
EXDECHO
1 other identifier
interventional
68
1 country
1
Brief Summary
The EXDECHO study is the first randomized study evaluating the effect of four body positions on diaphragmatic excursion in obese patients by ultrasound. The investigators suppose that the course of the right diaphragmatic hemicupola would be increased by an increasingly horizontal position (gradual increase in the diaphragmatic excursion from standing to lying down). If this hypothesis is confirmed, kinesitherapists will have more informed positioning choices to improve the effectiveness of respiratory rehabilitation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable obesity
Started May 2022
Typical duration for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 27, 2022
CompletedFirst Posted
Study publicly available on registry
May 12, 2022
CompletedStudy Start
First participant enrolled
May 31, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2024
CompletedAugust 10, 2022
August 1, 2022
2 years
April 27, 2022
August 7, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Diaphragmatic excursion in centimeters in the 4 positions measured by ultrasound
Day 0
Secondary Outcomes (5)
Correlation between measurement of diaphragmatic excursion in centimeters by ultrasound and weight in kilograms.
Day 0
Correlation between measurement of diaphragmatic excursion in centimeters by ultrasound and waist circumference in centimeters.
Day 0
Correlation between measurement of diaphragmatic excursion in centimeters by ultrasound and BMI in kg/m². Weight in kilograms and height in meters will be combined to report BMI in kg/m².
Day 0
Correlation between measurement of diaphragmatic excursion in centimeters by ultrasound and sex of the participant (male/female).
Day 0
Comfort of the ultrasound examination felt by the patient via a questionnaire
Day 0
Study Arms (4)
Order of body positions for ultrasound measurements : supine position, 45°, sitting, standing
EXPERIMENTALOrder of body positions for ultrasound measurements : 45°, sitting, standing, supine position.
EXPERIMENTALOrder of body positions for ultrasound measurements : sitting, standing, supine, 45°.
EXPERIMENTALOrder of body positions for ultrasound measurements : standing, supine, 45°, seated.
EXPERIMENTALInterventions
Measurement of the diaphragmatic excursion according to the position of the body by ultrasound
Eligibility Criteria
You may qualify if:
- to have a BMI greater than or equal to 30;
- to have not had intense physical activity during the hour preceding the measurements;
- to be enrolled in a social security plan;
- to give a written consent;
You may not qualify if:
- to have a respiratory pathology unrelated to obesity (sleep apnea syndrome, obesity-hypoventilation syndrome, restrictive ventilatory syndrome with no other known cause);
- to have a cardiac pathology not stabilized by drug treatment and/or resulting in heart failure and/or requiring the fitting of a pacemaker or defibrillator;
- to have a chronic inflammatory disease (rheumatoid arthritis, Crohn's disease, cirrhosis, etc.);
- to have a chest deformity (kyphoscoliosis, funnel chest, etc.);
- to be anactive smoking or former smoker (stopped for less than 3 months and total consumption \> 10 pack-years);
- to have an history of major surgery, surgery under general anesthesia for less than 3 months, or minimally invasive surgery for less than 1 year of the thoraco-abdomino-pelvic compartments;
- to have a known sensitivity to monopropylene glycol (substance present in the sterile ultrasound gel);
- temperature of the room in which the ultrasound measurements are carried out below 20°C or above 25°C;
- subject under a measure of legal protection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier Régional Universitaire de Nancy
Vandœuvre-lès-Nancy, 54511, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marine Mervelet
Central Hospital, Nancy, France
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 27, 2022
First Posted
May 12, 2022
Study Start
May 31, 2022
Primary Completion
May 30, 2024
Study Completion
November 30, 2024
Last Updated
August 10, 2022
Record last verified: 2022-08